Risk factors for cardiovascular disease and hormone therapy in women.

about

Mortality prediction in the elderly by an easily measured metabolic index.Smoking and drinking influence the advancing of ischemic stroke disease by targeting PTGS2 and TNFAIP3.

P2860

Q51361994-65F51F4D-828C-4145-BE14-7A12387470D6 Q55477432-D87C2EB5-D125-4E83-B71C-900B1A8D6B51

P2860

Risk factors for cardiovascular disease and hormone therapy in women.

Item

http://www.wikidata.org/entity/Q35771145

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Risk factors for cardiovascular disease and hormone therapy in women.

@ast

Risk factors for cardiovascular disease and hormone therapy in women.

@en

type

Item

label

Risk factors for cardiovascular disease and hormone therapy in women.

@ast

Risk factors for cardiovascular disease and hormone therapy in women.

@en

prefLabel

Risk factors for cardiovascular disease and hormone therapy in women.

@ast

Risk factors for cardiovascular disease and hormone therapy in women.

@en

P1476

Risk factors for cardiovascular disease and hormone therapy in women.

@en

P2093

P Collins

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity, Metabolic Syndrome, and Cardiovascular Disease

Prediction of Coronary Heart Disease Using Risk Factor Categories

Annual Deaths Attributable to Obesity in the United States

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

P304

iii24-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1136/HRT.2005.071787

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

92 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7166502

http://www.w3.org/2001/XMLSchema#string

P698

16614265

http://www.w3.org/2001/XMLSchema#string

P932

1860737

http://www.w3.org/2001/XMLSchema#string

Risk factors for cardiovascular disease and hormone therapy in women.

about

P2860

P2860

Risk factors for cardiovascular disease and hormone therapy in women.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932